Feature|Articles|November 15, 2024
- Pharmaceutical Executive: November 2024
- Volume 44
- Issue 11
Pharmaceutical Executive: November 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive November 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 1 year ago
AI’s Attention Spanabout 1 year ago
Noam Solomon: Bringing the Human Story to AIabout 1 year ago
ROI and Rare Disease: Retooling the ‘Gene’ Value Machineabout 1 year ago
The Leap Forward: Practical Gains for Pharma AI Useabout 1 year ago
Powering Pipelines Forward: Approach Science Differentlyabout 1 year ago
Navigating the Current Landscape for Pharma Leadersabout 1 year ago
Passage to Asia: Early Access for Innovative Therapiesabout 1 year ago
Digital Protection: Q&A with Jeffrey BernsteinNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
3
FDA Announces Agency-Wide Deployment of Agentic AI Tools
4
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
5
